BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27228506)

  • 1. Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.
    Sung FY; Lan CY; Huang CJ; Lin CL; Liu CJ; Chen PJ; Lin SM; Yu MW
    Hepatology; 2016 Sep; 64(3):720-31. PubMed ID: 27228506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
    Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
    Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
    Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma.
    Zhang KY; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    Cancer Sci; 2007 Dec; 98(12):1921-9. PubMed ID: 17888035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
    Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
    Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
    Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
    Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
    Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
    Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors analysis and a new risk scoring system predicting hepatocarcinogenesis for chronic genotype C HBV infected patients].
    Liu JL; Pu R; Ma LT; Wang S; Yin JH; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1459-1464. PubMed ID: 30462954
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.
    Yuen MF; Tanaka Y; Mizokami M; Yuen JC; Wong DK; Yuan HJ; Sum SM; Chan AO; Wong BC; Lai CL
    Carcinogenesis; 2004 Sep; 25(9):1593-8. PubMed ID: 15090469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].
    Zhang F; Shao YF; Gao JD; Xu Y; Liu GT; Xu LB; Wu ZY; Gao WH; Sun ZT
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1482-4. PubMed ID: 18275715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.